All In Biotech

Drug Trial Radar · NCT01087723

European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial

Multi-centre, Multi-national, Prospective, Randomised, Open-label, Comparison of Bivalirudin to Other Guideline Based Current Therapies (Excluding Bivalirudin)

Last checked: Nov 20, 2026Latest source record: Feb 12, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,198 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,198

Actual

Start

Mar 2010

Primary completion

Aug 2013

Study completion Aug 2014

Sponsor

Lead sponsor
The Medicines CompanyIndustry
Sponsor type
Industry
First posted
Mar 16, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To show that the early administration of bivalirudin improves 30 day outcomes when compared to the current standard of care in participants with ST segment elevation acute coronary syndrome (STE-ACS), intended for a primary percutaneous coronary intervention (PCI) management strategy, presenting either via ambulance or to centers where PCI is not performed.

Conditions

  • Acute Coronary Syndrome

Interventions

  • BivalirudinDrug

  • HeparinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Composite Incidence of Death and Non-coronary Artery Bypass Graft (CABG) Major BleedingTime frame: Within 30 days

Locations

145 sites in 9 countries. Site status is shown where the registry gives one.

  • Hanusch Krankenhaus

    Vienna, Austria

  • Magistratsabeilung 70, Wiener

    Vienna, Austria

  • Universitats-Klinik Fur

    Vienna, Austria

  • Wilhelminenspital MA 6 - BA 19

    Vienna, Austria

  • Zdravotnicka Zachranna Sluzba

    České Budějovice, Czechia

  • Aarhus Universitetshospital

    Aarhus, Denmark

  • Akutlaegebil Kobenhavn, Hc Andersens Boulevard 23

    Copenhagen, Denmark

  • Rigshospitalet

    Copenhagen, Denmark

  • Gentofte Hospital

    Hellerup, Denmark

  • Akutlaegebil Nordsjaelland

    Hillerød, Denmark

  • Laegeambulancen Odense

    Odense, Denmark

  • Odense Universitets Hospital

    Odense, Denmark

  • Hopital Europeen Paris La Roseraie

    Aubervilliers, France

  • Hospital Avicenne, Pharmacie -Gestion Des Essais Cliniques

    Bobigny, France

  • Chu De Bordeaux - Hopital Pellegrin

    Bordeaux, France

  • Centre Hospitalier Bourg En Bresse

    Bourg-en-Bresse, France

  • Clinique Convert

    Bourg-en-Bresse, France

  • Ch Jacques Coeur

    Bourges, France

  • Centre Hospitalier Universitaire De Caen

    Caen, France

  • Hopital Prive Saint Martin

    Caen, France

  • Service De Cardiologie

    Cedex, France

  • Ch Chateauroux

    Châteauroux, France

  • Chu Clermont-Ferrand, Hopital

    Clermont-Ferrand, France

  • Samu-Smur Chu Clermont-Ferrand

    Clermont-Ferrand, France

  • Hopital Beaujon

    Clichy, France

  • Ch Sud Francilien - Site Corbeil

    Corbeil Essonne, France

  • Ch Sud Francilien - Site Corbeil, Pharmacie

    Corbeil-Essonnes, France

  • Capio - Clinique Des Cedres

    Cornebarrieu, France

  • Hospital Henri Mondor, Pharmacie

    Créteil, France

  • Samu 92 Hauts De Seine

    Garches, France

  • Clinique Les Eaux Claires Ghm

    Grenoble, France

  • Chu A Michallon Grenoble

    La Tronche, France

  • Samu Chu A Michallon Grenoble

    La Tronche, France

  • Hopital Andre Mignot - Centre Hospitalier De Versailles

    Le Chesnay, France

  • Chr Lille

    Lille, France

  • Samu 59/Samu Du Nord

    Lille, France

  • Centre Hospitalier De Longjumeau

    Longjumeau, France

  • Centre Hospitalier St Joseph St Luc

    Lyon, France

  • Institut Hospitalier Jacques Cartier

    Massy, France

  • Centre Hospitalier De Montelimar

    Montélimar, France

Showing 40 of 145 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.